Schizophrenia and Related Disorders Alliance of America
This story appears to have been written by the PR department of the company that makes Invega- the first once-monthly atypicle antipsychotic approved for Schizophrenia in the United States.
Link to full article
Submitted by: Darrell H.
Powered by Robly™
This is the Secondary Sidebar Widget Area. You can add content to this area by visiting your Widgets Panel and adding new widgets to this area.
Copyright © 2008-2016 SARDAA · All Rights Reserved.